This update serves to correct three errors: Orchid generated $13.7 million in total revenue during the fourth quarter of 2003, not $12.6 million, as was reported. Additionally, Orchid's net earnings per share during the fourth quarter 2004 was $.03, not $.04, as was reported; and the company posted a net loss of $7.3 million during the fourth quarter of 2003, as opposed to $7.2 million, as was reported.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.